Studies

D740FC00001, Surovatamig, AbKD:

Internal Medicine Nephrology Kidney Disease Adult Subjects

The purpose of this study is to assess the safety, tolerability, pharmacokinetic, and efficacy of surovatamig administered by subcutaneous injection in adult participants with primary membranous nephropathy.